Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas

British Journal of Cancer

Volumn 104, Issue 8, 2011, Pages 1296-1302

  Handra Luca, A ^a,b   Hong, S M ^a   Walter, K ^a   Wolfgang, C ^a   Hruban, R ^a   Goggins, M ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITÉ PARIS 13   (France)

Author keywords

adenocarcinoma; pancreas; prognosis; vimentin

Indexed keywords

VIMENTIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL DIFFERENTIATION; DISEASE COURSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MESENCHYME; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 79954450849     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.93     Document Type: Article

References (50)

1. AJCC (2010) American Joint Committee on Cancer: AJCC Cancer Staging Manual. 7th edn. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) Springer: New York
2. Biankin AV, Morey AL, Lee CS, Kench JG, Biankin SA, Hook HC, Head DR, Hugh TB, Sutherland RL, Henshall SM (2002) DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma. J Clin Oncol 20: 4531-4542 (Pubitemid 35402956)
3. Blackford A, Serrano OK, Wolfgang CL, Parmigiani G, Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Eshleman JR, Goggins M, Jaffee EM, Iacobuzio-Donahue CA, Maitra A, Cameron JL, Olino K, Schulick R, Winter J, Herman JM, Laheru D, Klein AP, Vogelstein B, Kinzler KW, Velculescu VE, Hruban RH (2009) SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer. Clin Cancer Res 15: 4674-4679
4. Brauksiepe B, Mujica AO, Herrmann H, Schmidt ER (2008) The serine/ threonine kinase Stk33 exhibits autophosphorylation and phosphorylates the intermediate filament protein vimentin. BMC Biochem 9: 25
5. Chang DK, Johns AL, Merrett ND, Gill AJ, Colvin EK, Scarlett CJ, Nguyen NQ, Leong RW, Cosman PH, Kelly MI, Sutherland RL, Henshall SM, Kench JG, Biankin AV (2009) Margin clearance and outcome in resected pancreatic cancer. J Clin Oncol 27: 2855-2862
6. Chen CH, Wang PC (1991) Diagnostic plots in Cox's regression model. Biometrics 47: 841-850
7. Chen WD, Han ZJ, Skoletzky J, Olson J, Sah J, Myeroff L, Platzer P, Lu S, Dawson D, Willis J, Pretlow TP, Lutterbaugh J, Kasturi L, Willson JK, Rao JS, Shuber A, Markowitz SD (2005) Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 97: 1124-1132 (Pubitemid 41511211)
8. Christensen E (1987) Multivariate survival analysis using Cox's regression model. Hepatology 7: 1346-1358 (Pubitemid 18014213)
9. Colucci-Guyon E, Portier MM, Dunia I, Paulin D, Pournin S, Babinet C (1994) Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell 79: 679-694 (Pubitemid 24363811)
10. Corsini MM, Miller RC, Haddock MG, Donohue JH, Farnell MB, Nagorney DM, Jatoi A, McWilliams RR, Kim GP, Bhatia S, Iott MJ, Gunderson LL (2008) Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). J Clin Oncol 26: 3511-3516
11. Dellagi K, Vainchenker W, Vinci G, Paulin D, Brouet JC (1983) Alteration of vimentin intermediate filament expression during differentiation of human hemopoietic cells. EMBO J 2: 1509-1514
12. Domagala W, Lasota J, Dukowicz A, Markiewski M, Striker G, Weber K, Osborn M (1990a) Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas. Am J Pathol 137: 1299-1304
13. Domagala W, Yuml;niak L, Lasota J, Weber K, Osborn M (1990b) Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas. Am J Pathol 137: 1059-1064
14. Goggins M (2011) Markers of pancreatic cancer: working toward early detection. Clin Cancer Res (in press
15. Heatley M, Maxwell P, Whiteside C, Toner P (1993) Vimentin expression in benign and malignant breast epithelium. J Clin Pathol 46: 441-445 (Pubitemid 23167419)
16. Herman JM, Swartz MJ, Hsu CC, Winter J, Pawlik TM, Sugar E, Robinson R, Laheru DA, Jaffee E, Hruban RH, Campbell KA, Wolfgang CL, Asrari F, Donehower R, Hidalgo M, Diaz Jr LA, Yeo C, Cameron JL, Schulick RD, Abrams R (2008) Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol 26: 3503-3510
17. Hong SH, Misek DE, Wang H, Puravs E, Hinderer R, Giordano TJ, Greenson JK, Brenner DE, Simeone DM, Logsdon CD, Hanash SM (2006) Identification of a specific vimentin isoform that induces an antibody response in pancreatic cancer. Biomark Insights 1: 175-183
18. Hong SM, Li A, Olino K, Wolfgang CL, Herman JM, Schulick RD, Iacobuzio-Donahue C, Hruban RH, Goggins M (2011) Loss of E-cadherin xpression and outcome among patients with resectable pancreatic adenocarcinomas. Mod Pathol (in press
19. Hosmer DW, Lemeshow S (2000). Applied Logistic Regression 2nd edn Wiley: New York
20. Iacobuzio-Donahue CA, Fu B, Yachida S, Luo M, Abe H, Henderson CM, Vilardell F, Wang Z, Keller JW, Banerjee P, Herman JM, Cameron JL, Yeo CJ, Halushka MK, Eshleman JR, Raben M, Klein AP, Hruban RH, Hidalgo M, Laheru D (2009) DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol 27: 1806-1813
21. Infante JR, Matsubayashi H, Tonascia J, Tonascia J, Klein AP, Riall TA, Yeo C, Iacobuzio-Donahue C, Goggins M (2007) Perineoplastical fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma. J Clin Oncol 25: 319-325 (Pubitemid 350003021)
22. Ivaska J, Pallari HM, Nevo J, Eriksson JE (2007) Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res 313: 2050-2062 (Pubitemid 46842979)
23. Javle MM, Gibbs JF, Iwata KK, Pak Y, Rutledge P, Yu J, Black JD, Tan D, Khoury T (2007) Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer. Ann Surg Oncol 14: 3527-3533 (Pubitemid 350160113)
24. Kloppel G, Hruban RH, Longnecker DS, Adler G, Kern SE, Partanen TJ (2000) Ductal adenocarcinoma of the pancreas. In: Hamilton S, Aaltonen L (eds). WHO Classification of Digestive Neoplastia pp 220-230.
25. IARC Press: Lyon Klymkowsky MW, Savagner P (2009) Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am J Pathol 174: 1588-1593
26. Lahat G, Zhu QS, Huang KL, Wang S, Bolshakov S, Liu J, Torres K, Langley RR, Lazar AJ, Hung MC, Lev D (2010) Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies. PLoS One 16: e10105
27. Lazarides E, Granger BL, Gard DL, O'Connor CM, Breckler J, Price M, Danto SI (1982) Desmin- and vimentin-containing filaments and their role in the assembly of the Z disk in muscle cells. Cold Spring Harb Symp Quant Biol 1: 351-378 (Pubitemid 12033480)
28. Leader M, Collins M, Patel J, Henry K (1987) Vimentin: an evaluation of its role as a tumour marker. Histopathology 11: 63-72 (Pubitemid 17024336)
29. Li A, Omura N, Hong SM, Vincent A, Walter K, Griffith M, Borges M, Goggins M (2010) Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. Cancer Res 1: 5226-5237
30. Liu LK, Jiang XY, Zhou XX, Wang DM, Song XL, Jiang HB (2010) Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome. Mod Pathol 23: 213-224
31. Matsubayashi H, Infante JR, Winter J, Klein AP, Schulick R, Hruban R, Visvanathan K, Goggins M (2007) Neoplastic COX-2 expression and prognosis of patients with resectable pancreatic cancer. Cancer Biol Ther 6: 1569-1575 (Pubitemid 351590328)
32. McInroy L, Määttä A (2007) Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem Biophys Res Commun 17: 109-114 (Pubitemid 46990330)
33. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM, Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics (2005) Reporting recommendations for neoplastic marker prognostic studies. J Clin Oncol 23: 9067-9072
34. Medeiros LJ, Michie SA, Johnson DE, Warnke RA, Weiss LM (1988) An immunoperoxidase study of renal cell carcinomas: correlation with nuclear grade, cell type, and histologic pattern. Hum Pathol 19: 980-987
35. Naito Y, Iacobuzio-Donahue CA (2010) Biomarker profiles associated with metastatic pancreatic cancer. Modern Pathol 23: 366A
36. Nakajima S, Doi R, Toyoda E, Tsuji S, Wada M, Koizumi M, Tulachan SS, Ito D, Kami K, Mori T, Kawaguchi Y, Fujimoto K, Hosotani R, Imamura M (2004) N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res 10: 4125-4133 (Pubitemid 38812492)
37. Neureiter D, Zopf S, Dimmler A, Stintzing S, Hahn EG, Kirchner T, Herold C, Ocker M (2005) Different capabilities of morphological pattern formation and its association with the expression of differentiation markers in a xenograft model of human pancreatic cancer cell lines. Pancreatology 5: 387-397 (Pubitemid 41160276)
38. Nieminen M, Henttinen T, Merinen M, Marttila-Ichihara F, Eriksson JE, Jalkanen S (2006) Vimentin function in lymphocyte adhesion and transcellular migration. Nat Cell Biol 8: 156-162
39. Sato N, Fukushima N, Maehara N, Matsubayashi H, Koopmann J, Su GH, Hruban RH, Goggins M (2003) SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of neoplastic-stromal interactions. Oncogene 22: 5021-5030 (Pubitemid 37026400)
40. Schussler MH, Skoudy A, Ramaerkers F, Real FX (1992) Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer. Am J Pathol 140: 559-568
41. Shirahata A, Sakata M, Sakuraba K, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y, Hibi K (2009) Vimentin methylation as a marker for advanced colorectal carcinoma. Anticancer Res 29: 279-281
42. Tascilar M, Skinner HG, Rosty C, Sohn T, Wilentz RE, Offerhaus GJ, Adsay V, Abrams RA, Cameron JL, Kern SE, Yeo CJ, Hruban RH, Goggins M (2001) The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res 7: 4115-4121 (Pubitemid 34044636)
43. Traub PG, Perides G, Scherbarth A, Traub U (1985) Tenacious binding of lipids to vimentin during its isolation and purification from Ehrlich ascites neoplastic cells. FEBS Lett 193: 217-221 (Pubitemid 16163986)
44. Vincent A, Herman JM, Schulick R, Hruban R, Goggins M (2011) Pancreatic cancer. Lancet (in press
45. Walter K, Omura N, Hong SM, Griffith M, Vincent A, Borges M, Goggins M (2010) Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts. Clin Cancer Res 16: 1781-1789
46. Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, Hodgin MB, Sauter PK, Hruban RH, Riall TS, Schulick RD, Choti MA, Lillemoe KD, Yeo CJ (2006) 1423 Pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10: 1199-1210
47. Winter JM, Ting AH, Vilardell F, Gallmeier E, Baylin SB, Hruban RH, Kern SE, Iacobuzio-Donahue CA (2008) Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer. Clin Cancer Res 14: 412-418 (Pubitemid 351226108)
48. Zhao Y, Yan Q, Long X, Chen X, Wang Y (2008) Vimentin affects the mobility and invasiveness of prostate cancer cells. Cell Biochem Funct 26: 571-577
49. Zhu QS, Rosenblatt K, Huang KL, Lahat G, Brobey R, Bolshakov S, Nguyen T, Ding Z, Belousov R, Bill K, Luo X, Lazar A, Dicker A, Mills GB, Hung MC, Lev D (2011) Vimentin is a novel AKT1 target mediating motility and invasion. Oncogene 30: 457-470
50. Zou H, Harrington JJ, Shirc AM, Rego RL, Wang L, Campbell ME, Oberg AL, Ahlquist DA (2007) Highly methylated genes in colorectal neoplasia: implications for screening. Cancer Epidemiol Biomarkers Prev 16: 2686-2696 (Pubitemid 351196325)